Quantapore Developing Nanopore Sequencer for Low-Cost Genome Sequencing | GenomeWeb

This article was originally published Jan. 23.

Quantapore, a new Silicon Valley company, is working on a nanopore sequencing technology to analyze a human genome in less than one day at low cost.

According to the firm's website, it is developing "a novel, massively parallel sequencer, which will allow rapid, affordable and accurate sequencing of entire genomes."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.